P03277
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for P03277, covering 2019-07-12 to 2022-06-01. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics, Safety and Efficacy of P03277 in Pediatric Patients Undergoing Central Nervous System Contrast-enhanced MRI [Phase 2]